General Services Administration announces intention to acquire land on behalf of FDA in Montgomery County, Md., through an advertisement in the Dec. 14 Washington Post. Part of FDA's effort to consolidate its Washington-area facilities into a two-site campus, the Montgomery County site will house the Center for Drug Evaluation and Research and the Center for Devices and Radiological Health. GSA is seeking "no less than 133 contiguous buildable acres" that are adequately zoned to accomodate 1 mil. gross sq. ft. of office and lab space and 1,330 parking spaces. GSA wants responses by Jan. 29.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth